MET and neoplasm: Even though MGCD265 treatment significantly impaired tumor growth in all of the TNBC lines, complete growth inhibition after 3 weeks of treatment was only observed in the TNBC lines that had 4–5 MET copies and a positive growth trend can be observed in tumors without MET gene copy gain (Figure 4A).